Article Details
Retrieved on: 2023-01-11 05:37:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Piper Jaffray analysts reportedly increased their price target for Sutro Biopharma (NASDAQ: STRO) in a research note published on Tuesday.
Article found on: beststocks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here